Risk of HIV infection in studies of African women using hormonal contraceptives

(PLOS) Use of the injectable progestin contraceptive depot-medroxyprogesterone acetate is linked to an increased risk for HIV infection, according to an article published by Charles Morrison of FHI 360 and colleagues in this week's PLOS Medicine. The researchers did not find a significantly increased risk for HIV infection in women who used a different injectable progestin, norethisterone enanthate, nor in those who used combined oral contraceptives.
Source: EurekAlert! - Social and Behavioral Science - Category: Global & Universal Source Type: news